Back to Search Start Over

Diversity of the clinical presentation of the MMR gene biallelic mutations

Authors :
Pierre Vabres
Emilie Bouvignies
Gaëlle Bougeard
Mario Tosi
Stéphanie Baert-Desurmont
Julie Tinat
David Malka
Brigitte Bressac-de Paillerets
Frédéric Huet
Laurence Olivier-Faivre
Caroline Chapusot
Cosette Martin
G. Couillault
Stéphanie Vasseur
Thierry Frebourg
Florence Le Pessot
Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND)
Université de Rouen Normandie (UNIROUEN)
Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Lipides - Nutrition - Cancer [Dijon - U1231] (LNC)
Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement
Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques
Service de génétique [Rouen]
CHU Rouen
Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN)
Normandie Université (NU)
Université de Technologie de Compiègne (UTC)
Service de pédiatrie (CHU de Dijon)
Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)
Source :
Familial Cancer, Familial Cancer, Springer Verlag (Germany), 2014, 13 (1), pp.131-135. ⟨10.1007/s10689-013-9676-1⟩
Publication Year :
2014
Publisher :
HAL CCSD, 2014.

Abstract

International audience; Constitutional mismatch repair-deficiency, due to biallelic mutations of MMR genes, results in a tumour spectrum characterized by leukaemias, lymphomas, brain tumours and adenocarcinomas of the gastro-intestinal tract, occurring mostly in childhood. We report here two families illustrating the phenotypic diversity associated with biallelic MMR mutations. In the first family, two siblings developed six malignancies including glioblastoma, lymphoblastic T cell lymphoma, rectal and small bowel adenocarcinoma with onset as early as 6 years of age. We showed that this dramatic clinical presentation was due to the presence of two complex genomic PMS2 deletions in each patient predicted to result into complete PMS2 inactivation. In the second family, the index case presented with an early form of Lynch syndrome with colorectal adenocarcinomas at ages 17 and 20 years, and urinary tract tumours at the age of 25 years. We identified in this patient two MSH6 mutations corresponding to a frameshift deletion and an in frame deletion. The latter was not predicted to result into complete inactivation of MSH6. These reports show that the clinical expression of biallelic MMR mutations depends on the biological impact of the second MMR mutation and that, in clinical practice, the presence of a second MMR mutation located in trans should also be considered in patients suspected to present a Lynch syndrome with an unusual early-onset of tumours.

Details

Language :
English
ISSN :
13899600 and 15737292
Database :
OpenAIRE
Journal :
Familial Cancer, Familial Cancer, Springer Verlag (Germany), 2014, 13 (1), pp.131-135. ⟨10.1007/s10689-013-9676-1⟩
Accession number :
edsair.doi.dedup.....459320af0e16285cc79b6db05da0a690
Full Text :
https://doi.org/10.1007/s10689-013-9676-1⟩